Susceptibilities of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (Synercid) compared to its susceptibilities to reference macrolides and quinolones

被引:34
作者
Bråbäck, M [1 ]
Riesbeck, K [1 ]
Forsgren, A [1 ]
机构
[1] Lund Univ, Dept Med Microbiol, Malmo Univ Hosp, S-20502 Malmo, Sweden
关键词
D O I
10.1128/AAC.46.4.1114-1116.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The susceptibility pattern of Mycobacterium marinum was determined. Quinupristin-dalfopristin and telithromycin were less active than clarithromycin. Linezolid showed good antimicrobial activity at clinically achievable concentrations. Gatifloxacin, levofloxacin, and moxifloxacin displayed activities similar to those of ciprofloxacin. Gemifloxacin was less active. The Etest method showed variable agreement with the reference method.
引用
收藏
页码:1114 / 1116
页数:3
相关论文
共 20 条
[1]   Antibiotic susceptibility pattern of Mycobacterium marinum [J].
Aubry, A ;
Jarlier, V ;
Escolano, S ;
Truffot-Pernot, C ;
Cambau, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) :3133-3136
[2]   CLARITHROMYCIN - A POTENT AGENT AGAINST INFECTIONS DUE TO MYCOBACTERIUM-MARINUM [J].
BONNET, E ;
DEBATZOGUEREH, D ;
PETIT, N ;
RAVAUX, I ;
GALLAIS, H .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (04) :664-666
[3]   Linezolid [J].
Clemett, D ;
Markham, A .
DRUGS, 2000, 59 (04) :815-827
[4]   MYCOBACTERIUM-MARINUM INFECTIONS IN MAN [J].
COLLINS, CH ;
GRANGE, JM ;
NOBLE, WC ;
YATES, MD .
JOURNAL OF HYGIENE, 1985, 94 (02) :135-139
[5]   MYCOBACTERIUM-MARINUM SKIN INFECTIONS - REPORT OF 31 CASES AND REVIEW OF THE LITERATURE [J].
EDELSTEIN, H .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (12) :1359-1364
[6]   Mycobacterium marinum wrist arthritis: Local and systematic dissemination caused by concomitant immunosuppressive therapy [J].
Ekerot, L ;
Jacobsson, L ;
Forsgren, A .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1998, 30 (01) :84-87
[7]   In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials [J].
Fernández-Roblas, R ;
Esteban, J ;
Cabria, F ;
López, JC ;
Jiménez, MS ;
Soriano, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (01) :181-182
[8]   Application of the Etest to the antimicrobial susceptibility testing of Mycobacterium marinum clinical isolates [J].
Flynn, CM ;
Kelley, CM ;
Barrett, MS ;
Jones, RN .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (08) :2083-2086
[9]   ANTIBIOTIC SUSCEPTIBILITY OF MYCOBACTERIUM-MARINUM [J].
FORSGREN, A .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1993, 25 (06) :779-782
[10]   In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin [J].
Fung-Tomc, J ;
Minassian, B ;
Kolek, B ;
Washo, T ;
Huczko, E ;
Bonner, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (04) :437-446